Danaher appointed Julie Sawyer Montgomery as President and Chief Executive Officer effective October 1, 2026, as Rainer M. Blair ceases serving as President and CEO and transitions to Senior Advisor through December 31, 2026.
| IndividualJulie Sawyer MontgomeryRainer M. Blair | RolePresident and Chief Executive Officer; also appointed to Board and Executive, Finance and Science & Technology CommitteesPresident and Chief Executive Officer (will cease); will serve as Senior Advisor (employee) through Dec 31, 2026, then consultant through Mar 31, 2027 | Type of ChangeAppointedResigned from CEO and Board; transitioned to advisory/consultancy roles | Effective DateOctober 1, 2026October 1, 2026 (Advisory Period through Dec 31, 2026; Consultancy Period through Mar 31, 2027) | ReasonBoard appointment/succession (no arrangements or family relationships disclosed)Succession to support leadership transition | Replacement InfoReplaces Rainer M. Blair as President and CEOSucceeded by Julie Sawyer Montgomery as President and CEO | Background DetailsWith Danaher since 2017; Danaher officer since 2024; former President of Beckman Coulter Diagnostics (Jan 2020–Dec 2022); VP – Group Executive, Diagnostics (Jan 2023–Jun 2024); EVP since Jul 2024Will continue vesting of outstanding equity during Advisory Period; eligible for full 2026 cash incentive during Advisory Period; will receive monthly consultancy fees during Consultancy Period | Board/Committee Role ChangesAppointed to Board and to Executive, Finance and Science & Technology CommitteesResigned from Board and from Executive, Finance and Science & Technology Committees |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.